Kimelman & Baird’s National Healthcare NHC Stock Holding History

Kimelman & Baird’s Portfolio NHC Stock Details NHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-30,000	Closed	–	–	102
2013 Q2	$0	Buy	+30,000	New	+$1.4M	﹤0.01%	96

Other funds holding NHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Kimelman & Baird's NHC Position: Q3 2013 in Review

Kimelman & Baird sold out of National Healthcare (NHC) in Q3 2013, closing a stake of 30,000 shares.

Kimelman & Baird first reported a position in NHC in Q2 2013 and held it in 1 quarter. The position peaked at $0 in Q2 2013. 78 funds tracked by Wall St. Rank hold NHC as of Q3 2013.

Kimelman & Baird reported no remaining National Healthcare position as of Q3 2013 after selling out during the quarter.
Kimelman & Baird sold 30,000 National Healthcare shares in Q3 2013.
Kimelman & Baird first reported a position in National Healthcare in Q2 2013 and held it in 1 quarter.
Kimelman & Baird's National Healthcare position peaked at $0 in Q2 2013.
78 funds tracked by Wall St. Rank held National Healthcare as of Q3 2013.

Based on Kimelman & Baird's 13F filing for Q3 2013, filed 13 Nov 2013.